Ocugen, Inc. (OCGN)
Nasdaq: OCGN · Biological Products, (No Diagnostic Substances) · Malvern, PA · filing with the SEC since 2006
Filings
506 filings since 2017 beside 236 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Jul 30, 2026.
Filings a yearinsider forms included
112781187672665462
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Jun 3, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Jul 1, 2025.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Jul 8, 2024.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Apr 1, 2024.SEC letters: 4 in the last 36 months, the newest Feb 11, 2025.A late-filing notice, Form NT 10-K, filed Apr 1, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Oct 15, 2026
8-K items 1.01, 7.01, 8.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD); Other event · Current report
Oct 13, 2026
Sep 8, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Sep 1, 2026
May 14, 2026
8-K items 5.02, 8.01
Officer or director change; Other event · Current report
May 8, 2026
May 14, 2026
8-K items 2.03, 3.02, 7.01, 9.01
New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
May 7, 2026
8-K items 1.01, 1.02, 2.02, 2.03, 3.02, 9.01
Major agreement signed; Major agreement ended; Results released; New debt or obligation taken on; Shares sold without registration · Current report
May 4, 2026
8-K items 2.02, 7.01, 8.01, 9.01
Results released; Investor disclosure (Regulation FD); Other event · Current report
40 of 506 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.